GSK
This article was originally published in The Tan Sheet
Executive Summary
Firm changes ad agencies for some consumer products due to integration of Block Drug earlier this year. Effective January 2002, Sensodyne and Poligrip accounts will be handled by Grey Worldwide (New York); previous agencies were Carrafiello-Diehl & Associates (Irvington, N.Y.) and Publicis (New York), respectively. Publicis will take Phazyme from Grey Worldwide, while Arnold McGrath Worldwide (Boston) gains Citrucel from Ogilvy & Mather (New York)...
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.